GlaxoSmithKline Pharmaceuticals has informed that the restricted trading period in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company’s shares is closed from October 01, 2015 and shall reopen on November 03, 2015 i.e. after the approval and declaration of Unaudited Financial Results for the quarter ended September 30, 2015, by the Board of Directors at its meeting scheduled to be held on October 31, 2015.
The above information is a part of company’s filings submitted to BSE.
